Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Capsule for treating myocarditis of coxsackie B virus type, and its prepn.method

A technology for viral myocarditis and capsules, applied in the directions of antiviral agents, capsule delivery, pharmaceutical formulations, etc., can solve the problems of unstable curative effect, inconvenient taking, slow onset of effect, etc., and achieve novel treatment plan, convenient taking and remarkable effect. Effect

Inactive Publication Date: 2004-10-20
TANGSHAN VOCATIONAL & TECHN COLLEGE +4
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it is unsatisfactory due to shortcomings such as weak pertinence, unstable curative effect, poor repeatability, and inconvenient taking.
In addition, the clinical medicine of traditional Chinese medicine is mainly based on decoction, which has a slow onset of action, lack of specificity, and a large loss of medicinal components, which does not meet the needs of the modern high-paced competitive society.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0011] Below by embodiment this is further described.

[0012] Select traditional Chinese medicine American ginseng, radish seed, wang buliuxing, Schisandra chinensis, Ophiopogon japonicus, paeonol, and astragalus, wash and dry. Configured according to weight percentage, the weight percentage of each traditional Chinese medicine component is as follows: American ginseng 15-30%, radish seed 5-15%, Wang Buliuxing 4-10%, Schisandra 4-15%, Ophiopogon japonicus 5-20%, dandelion Skin 10-25%, Astragalus 30-40%. Grinding and packing into capsules, grinding the above-mentioned traditional Chinese medicine components, mixing them uniformly, filling them into capsules according to the required weight, and making anti-Coxsackie B virus myocarditis capsules.

[0013] The present invention obtains unexpected therapeutic effect through clinical application, and the clinical curative effect report is as follows:

[0014] 1 Clinical data

[0015] 1.1 Cases and administration ACCM group: 60 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A Chinese medicine in the form of capsule for treating Coxsackie B viral myocarditis is prepared from 2-7 Chinese-medicinal materials including American ginseng, radish seed, vaccaria seed, astragalus root, etc. Its advantage is high curative effect (85% for total effective rate).

Description

Technical field: [0001] The invention relates to a traditional Chinese medicine capsule and a preparation method thereof, in particular to an anti-Coxsackie B virus myocarditis capsule and a preparation method thereof. Background technique: [0002] At present, myocarditis refers to the inflammatory lesion of the myocardium itself. Clinically, myocarditis caused by Coxsackie B virus infection is the most common in recent years. To the treatment of this disease, doctor trained in Western medicine is except bed rest, nutrition therapy and symptom-checking treatment at present, still does not have specific medicine. Traditional Chinese medicine treatment adopts methods such as heat-clearing, detoxifying, replenishing qi, nourishing yin (blood), promoting blood circulation to treat more, and certain curative effect is arranged. However, it is unsatisfactory due to weak pertinence, unstable curative effect, poor repeatability, and inconvenient taking. In addition, the clinical ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/48A61P9/00A61P31/12
Inventor 李曼包巨太邢纪萍王爽敏
Owner TANGSHAN VOCATIONAL & TECHN COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products